Fusion of engineered albumin with factor IX Padua extends half-life and improves coagulant activity.

Br J Haematol · 2021 · PMC8362221 · PMID 34109608

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

slightly significantno p-value reported

A slightly significant shortening of coagulation times for reference fusions over the baseline was detectable only for Idelvion until day 1.

also in 1,750 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.